BioRestorative issued 3 patents for stem cell platform
BioRestorative Therapies has been issued three separate patents related to the company's metabolic ThermoStem stem cell program. Read More
Scientists uncover secrets to controlling gene expression
Bioengineers have demonstrated that simultaneous control over transcription and translation in cells can achieve the most stringent control of gene expression to date. The findings, published in Nature Communications on March 19, will open new avenues for improved biotechnologies and synthetic biology applications. Read More
Standards nonprofit launches online portal
The Standards Coordinating Body has launched an online portal to provide access to published standards and to those in development. Read More
Cell Source issued 2 patents for Veto Cell technology
The U.S. Patent and Trademark Office has issued Cell Source two patents covering its Veto Cell technology, which is used in immunotherapies to facilitate mismatched donor stem cell transplants. Read More
Fujifilm picks Holly Springs for new facility
Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization for biologics, viral vaccines, and gene therapies, announced it will build what will be the country's largest cell culture production facility in Holly Springs, NC. Read More
ONK strengthens cell therapy manufacturing capabilities
ONK Therapeutics has entered into a license agreement with the U.S. National Institutes of Health to gain rights to make and use clinically validated good manufacturing practice-grade feeder cell lines that will enable robust natural killer cell expansion to support the scale up of the company's manufacturing process. Read More
Cytovia ramps up production of NK cells ahead of trials
Cytovia Therapeutics has signed two agreements for research and development and manufacturing operations to move the company's chimeric antigen receptor-natural killer (NK) cells derived from universal induced pluripotent stem cells toward clinical trials in the fourth quarter of 2021. Read More
Antion launches allogeneic miCAR T-cell tech
Antion Biosciences has launched its allogeneic miCAR T-cell technology platform (miCAR), which has the ability to simultaneously silence and express therapeutic proteins. Read More
PerkinElmer, Insightful Science to integrate software with cloud-based data
PerkinElmer has inked a collaboration with Insightful Science through which it will expand its documentation, workflow, and decision-making Signals informatics platform to expand its offerings in biologics drug discovery. Read More
Axol Bioscience to merge with Censo Biotechnologies
Provider of induced pluripotent stem cell-derived cells, media, and characterization services Axol Bioscience and contract research organization Censo Biotechnologies have signed a merger agreement. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter